Suchergebnisse - "Fengkai Xu"

PubPharm (6)

1

Genomic profiling and associated B cell lineages delineate the efficacy of neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinomaResearch in context

in: EBioMedicine | 2024

von Hongyu Zhang | Haoyu Wen | Qiaoliang Zhu | +12

2

Development of a ferroptosis-based model to predict prognosis, tumor microenvironment, and drug response for lung adenocarcinoma with weighted genes co-expression network analysis

in: Frontiers in Pharmacology | 2022

von Tao Cheng | Guangyao Shan | Huiqin Yang | +4

3

An individual nomogram can reliably predict tumor spread through air spaces in non-small-cell lung cancer

in: BMC Pulmonary Medicine | 2022

von Shuai Wang | Huankai Shou | Haoyu Wen | +8

4

Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma

in: EBioMedicine | 2021

von Yin Li | Fengkai Xu | Fanghua Chen | +4

5

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

in: BMC Cancer | 2019

von Yin Li | Di Ge | Jie Gu | +3

6

Large Cell Neuroendocrine Carcinoma Shares Similarity with Small Cell Carcinoma on the Basis of Clinical and Pathological Features

in: Translational Oncology | 2019

von Fengkai Xu | Ke Chen | Chunlai Lu | +5

1
[1]